Ume.ang., Sweden

Goran Wadell

This inventor holds 2 USPTO granted patents. Top assignees: Symbicom Ab, Symbicom Aktiebolag. Active years: 1989-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 82(Granted Patents)


Company Filing History:


Years Active: 1989-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Goran Wadell: Innovator in Antiviral Agents

Introduction

Goran Wadell is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of antiviral agents, holding 2 patents that focus on innovative solutions for viral infections. His work is characterized by a deep understanding of virus binding mechanisms and their implications for treatment.

Latest Patents

Wadell's latest patents revolve around the discovery of a second-step virus binding receptor found in nature on the surface of animal and plant cells. This receptor is essential for virus penetration into target cells. His research indicates that this second-step receptor can bind a wide variety of viruses from different families. The natural or synthetic substances that correspond to the binding epitope of this receptor are indicated for the diagnosis, prophylaxis, or treatment of viral infections.

Career Highlights

Throughout his career, Goran Wadell has worked with various companies, including Symbicom AB and Symbicom Aktiebolag. His expertise in antiviral research has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Wadell has collaborated with notable individuals in his field, including Karl-Anders Karlsson and Erling Norrby. These partnerships have contributed to the advancement of his research and the successful application of his inventions.

Conclusion

Goran Wadell's innovative work in antiviral agents showcases his commitment to addressing viral infections through scientific research and collaboration. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…